Online citations, reference lists, and bibliographies.
← Back to Search

Relation Of A Hypoxia Metagene Derived From Head And Neck Cancer To Prognosis Of Multiple Cancers.

S. Winter, F. Buffa, Priyamal Silva, C. Miller, H. Valentine, H. Turley, K. Shah, Graham J. Cox, R. Corbridge, J. Homer, B. Musgrove, N. Slevin, P. Sloan, P. Price, C. West, A. Harris
Published 2007 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Affymetrix U133plus2 GeneChips were used to profile 59 head and neck squamous cell cancers. A hypoxia metagene was obtained by analysis of genes whose in vivo expression clustered with the expression of 10 well-known hypoxia-regulated genes (e.g., CA9, GLUT1, and VEGF). To minimize random aggregation, strongly correlated up-regulated genes appearing in >50% of clusters defined a signature comprising 99 genes, of which 27% were previously known to be hypoxia associated. The median RNA expression of the 99 genes in the signature was an independent prognostic factor for recurrence-free survival in a publicly available head and neck cancer data set, outdoing the original intrinsic classifier. In a published breast cancer series, the hypoxia signature was a significant prognostic factor for overall survival independent of clinicopathologic risk factors and a trained profile. The work highlights the validity and potential of using data from analysis of in vitro stress pathways for deriving a biological metagene/gene signature in vivo.
This paper references
10.1038/sj.bjc.6600215
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
K. Turner (2002)
10.1016/S0360-3016(02)02848-1
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
M. Koukourakis (2002)
10.1093/bioinformatics/bti605
Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis
C. Wilson (2005)
10.1186/bcr1168
Outcome signature genes in breast cancer: is there a unique set?
I. Kela (2005)
10.1038/nrc704
Hypoxia — a key regulatory factor in tumour growth
A. Harris (2002)
10.1002/(SICI)1097-0347(199903)21:2<146::AID-HED8>3.0.CO;2-U
Tissue oxygen distribution in head and neck cancer patients
M. Adam (1999)
10.1016/S0959-8049(01)00361-6
Hypoxia as a target for combined modality treatments.
B. Wouters (2002)
10.1023/B:CANC.0000031768.89246.d7
Hypoxic gene expression and metastasis
Q. Le (2004)
10.1002/ijc.1440
Estimating the world cancer burden: Globocan 2000
D. Parkin (2001)
10.1002/CHIN.200513286
Cellular Reaction to Hypoxia: Sensing and Responding to an Adverse Environment
I. Papandreou (2005)
10.3322/CANJCLIN.44.1.7
Cancer statistics, 1994
C. Boring (1994)
A geneexpression signature as a predictor of survival in breast cancer
MJ van de Vijver (2009)
American Association for Cancer cancerres.aacrjournals.org Downloaded from
(2007)
10.1385/1-59259-364-X:149
Statistical methods for identifying differentially expressed genes in DNA microarrays.
John M. D. Storey (2003)
10.1038/415530a
Gene expression profiling predicts clinical outcome of breast cancer
L. J. Veer (2002)
Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
E. Hui (2002)
Hypoxia Gene Signature www.aacrjournals.org 3449 Cancer Res
(2007)
10.1158/1078-0432.CCR-05-1447
Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy
H. Dressman (2006)
10.1056/NEJMOA021967
A gene-expression signature as a predictor of survival in breast cancer.
M. J. van de Vijver (2002)
Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.
M. Koukourakis (2001)
10.1016/J.RADONC.2005.06.038
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.
M. Nordsmark (2005)
10.1186/1471-2164-5-94
Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data
R. Shen (2004)
10.1097/00005537-200204000-00005
Analysis of Treatment Results for Oral Tongue Cancer
D. Sessions (2002)
10.1371/journal.pmed.0030047
Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers
Jen-Tsan Chi (2006)
10.1074/jbc.272.10.6510
Metaxin Is a Component of a Preprotein Import Complex in the Outer Membrane of the Mammalian Mitochondrion*
L. Armstrong (1997)
10.1198/016214504000000683
A Model-Based Background Adjustment for Oligonucleotide Expression Arrays
Z. Wu (2004)
10.1016/S1053-4296(96)80035-X
Hypoxic Stress Proteins: Survival of the Fittest.
Giaccia (1996)
Binding and regulation of HIF-1alpha by a subunit of the proteasome complex, PSMA7.
S. Cho (2001)
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.
J. Loncaster (2001)
10.1093/bioinformatics/btg405
affy - analysis of Affymetrix GeneChip data at the probe level
L. Gautier (2004)
Estimating the world cancer
DM Parkin (2000)
10.1038/sj.onc.1206703
Investigating hypoxic tumor physiology through gene expression patterns
N. Denko (2003)
10.1158/1078-0432.CCR-03-0248
Molecular Marker Profiles Predict Locoregional Control of Head and Neck Squamous Cell Carcinoma in a Randomized Trial of Continuous Hyperfractionated Accelerated Radiotherapy
F. Buffa (2004)
10.1038/sj.onc.1203703
Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays
Chidchanok Leethanakul (2000)
10.1002/cncr.21293
Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma
Peter Choi (2005)
10.1093/bioinformatics/bth469
Outcome signature genes in breast cancer: is there a unique set?
Liat Ein-Dor (2005)
Hypoxic gene expression and metastasis : Basic radiation into the new millennium
Q. Le (2004)
10.1038/ng1502
An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas
P. Roepman (2005)
10.1054/bjoc.2001.2018
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
A. Giatromanolaki (2001)
10.1016/S1359-6349(07)70161-1
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression.
C. Chung (2004)
Investigat - ing hypoxic tumor physiology through gene expression patterns
NC Denko
10.1038/nrc1187
Targeting HIF-1 for cancer therapy
G. Semenza (2003)
10.1074/jbc.M508454200
Deregulation of Proteasome Function Induces Abl-mediated Cell Death by Uncoupling p130CAS and c-CrkII*
Monica Holcomb (2006)
10.1002/GEPI.1124
Empirical bayes methods and false discovery rates for microarrays
B. Efron (2002)
10.1056/NEJMOA032641
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
J. Bernier (2004)
10.1200/JCO.2003.11.132
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
D. Swinson (2003)
Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.
D. Aebersold (2001)
10.1073/PNAS.0409462102
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.
H. Chang (2005)
10.1074/jbc.M001448200
Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide*
J. König (2000)



This paper is referenced by
10.1158/0008-5472.CAN-07-5644
Subtypes of breast cancer show preferential site of relapse.
M. Smid (2008)
10.1371/journal.pone.0010345
MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU
E. Favaro (2010)
10.1038/bjc.2017.66
Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma
Y. Suh (2017)
10.18632/oncotarget.9549
Current relevance of hypoxia in head and neck cancer
M. Bredell (2016)
Predictive Biomarkers and Personalized Medicine A 26-Gene Hypoxia Signature Predicts Bene fi t fromHypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer
A. Eustace (2013)
10.1002/cncr.25009
hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer
H. Gee (2010)
10.1158/1078-0432.CCR-15-2322
Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer
C. S. Fjeldbo (2016)
10.1016/j.ejphar.2011.01.063
Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX.
Margarita T Murri-Plesko (2011)
10.1158/1078-0432.CCR-07-1755
hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer
C. Camps (2008)
10.1016/j.semcancer.2020.01.003
Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy.
R. A. Khouzam (2020)
10.1007/978-1-4614-9167-5_6
Carbonic Anhydrase IX: From Biology to Therapy
S. Pastoreková (2014)
10.1007/s11864-017-0472-2
Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
L. Tonella (2017)
Association between hypoxic volume and underlying hypoxia-induced gene 1 expression in oropharyngeal squamous cell carcinoma ( OPSCC ) 2
Y. Suh (2017)
MOLECULAR DETERMINANTS OF RESIDUAL DISEASE IN OVARIAN CANCER
K. Gharpure (2017)
10.18632/ONCOTARGET.395
Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation
M. Sheffer (2011)
10.1038/bjc.2014.604
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
H. B. Ragnum (2015)
10.1016/j.radonc.2011.03.004
Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis.
J. Overgaard (2011)
10.1186/1755-8794-4-3
Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures
C. Fan (2010)
10.1002/hed.21975
Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment
A. Lucs (2013)
Research approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients
P. Fardin (2010)
HYPOXIA MEDIATED DOWNREGULATION OF MIRNA BIOGENESIS LEADS TO INCREASED TUMOR PROGRESSION
R. Rupaimoole (2014)
10.1371/journal.pgen.1004898
Integrative Analysis of DNA Methylation and Gene Expression Data Identifies EPAS1 as a Key Regulator of COPD
Seungyeul Yoo (2015)
10.18632/oncotarget.8014
Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers
J. Bradford (2016)
10.3109/02841861003614343
Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro
B. Sørensen (2010)
10.1259/bjr.20150009
Personalized radiotherapy: concepts, biomarkers and trial design.
A. H. Ree (2015)
10.1186/1471-2407-7-182
Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer
J. X. Yu (2007)
10.1111/j.1464-410X.2008.07647.x
The use of positron‐emission tomography in the diagnosis of tumour phenotype
C. Divgi (2008)
Therapeutics , Targets , and Chemical Biology Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
Kasper Toustrup (2011)
10.1016/j.drudis.2008.03.003
The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
J. Foekens (2008)
10.1016/j.stem.2014.01.005
Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.
A. Pietras (2014)
10.1158/0008-5472.CAN-12-1085
Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI.
Cathinka Halle (2012)
10.1038/bjc.2011.66
Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples
J. Hall (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar